Search research articles
Contact Us
Filters
Showing results (111-120 of 240) with videos related to
Page
of 24
Sort By:
International Journal of Cardiology
|
December 18, 2013
Haptoglobin genotype does not predict extent of coronary artery calcification in a prospective cohort of patients with type 2 diabetes
Ronen Jaffe, Emanuel Harari, Tamar Gaspar, et al.
American Heart Journal
|
December 13, 2005
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
Basil S Lewis, Shamir R Mehta, Keith A A Fox, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 16, 2023
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
Heinz Drexel, Juan Tamargo, Juan Carlos Kaski, et al.
The American Journal of Cardiology
|
November 13, 2007
Impact of 64-slice cardiac computed tomographic angiography on clinical decision-making in emergency department patients with chest pain of possible myocardial ischemic origin
Ronen Rubinshtein, David A Halon, Tamar Gaspar, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 17, 2020
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
Seif El Hadidi, Giuseppe Rosano, Juan Tamargo, et al.
Archives of Internal Medicine
|
August 16, 2006
Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure
Alon Barsheshet, Moshe Garty, Ehud Grossman, et al.
The Israel Medical Association Journal : IMAJ
|
May 12, 2007
The management, early and one year outcome in hospitalized patients with heart failure: a national Heart Failure Survey in Israel--HFSIS 2003
Moshe Garty, Avraham Shotan, Shmuel Gottlieb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 13, 2019
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
Heinz Drexel, Giuseppe M C Rosano, Basil S Lewis, et al.
Cardiology
|
October 10, 2002
Myocardial perfusion abnormalities early (12-24 h) after coronary stenting or balloon angioplasty: implications regarding pathophysiology and late clinical outcome
Ronen Jaffe, Simona Ben Haim, Basheer Karkabi, et al.
Cardiology
|
March 29, 2006
Reevaluation of routine invasive strategy versus noninvasive testing following uncomplicated ST-elevation myocardial infarction
Ronen Jaffe, David A Halon, Simona Ben Haim, et al.
Page
of 24
Search research articles
Search
Showing results (111-120 of 240) with videos related to
Sort By:
Page
of 24
International Journal of Cardiology
|
December 18, 2013
Haptoglobin genotype does not predict extent of coronary artery calcification in a prospective cohort of patients with type 2 diabetes
Ronen Jaffe, Emanuel Harari, Tamar Gaspar, et al.
American Heart Journal
|
December 13, 2005
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
Basil S Lewis, Shamir R Mehta, Keith A A Fox, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 16, 2023
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
Heinz Drexel, Juan Tamargo, Juan Carlos Kaski, et al.
The American Journal of Cardiology
|
November 13, 2007
Impact of 64-slice cardiac computed tomographic angiography on clinical decision-making in emergency department patients with chest pain of possible myocardial ischemic origin
Ronen Rubinshtein, David A Halon, Tamar Gaspar, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 17, 2020
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
Seif El Hadidi, Giuseppe Rosano, Juan Tamargo, et al.
Archives of Internal Medicine
|
August 16, 2006
Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure
Alon Barsheshet, Moshe Garty, Ehud Grossman, et al.
The Israel Medical Association Journal : IMAJ
|
May 12, 2007
The management, early and one year outcome in hospitalized patients with heart failure: a national Heart Failure Survey in Israel--HFSIS 2003
Moshe Garty, Avraham Shotan, Shmuel Gottlieb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 13, 2019
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
Heinz Drexel, Giuseppe M C Rosano, Basil S Lewis, et al.
Cardiology
|
October 10, 2002
Myocardial perfusion abnormalities early (12-24 h) after coronary stenting or balloon angioplasty: implications regarding pathophysiology and late clinical outcome
Ronen Jaffe, Simona Ben Haim, Basheer Karkabi, et al.
Cardiology
|
March 29, 2006
Reevaluation of routine invasive strategy versus noninvasive testing following uncomplicated ST-elevation myocardial infarction
Ronen Jaffe, David A Halon, Simona Ben Haim, et al.
Page
of 24